"No, my name's not on the lease at all": an interpretive phenomenological analysis of unstable housing and hepatitis C among people who inject drugs

被引:0
|
作者
McColl, Roisin [1 ,2 ]
Higgs, Peter [1 ,3 ]
Harney, Brendan [1 ,2 ,4 ,5 ]
机构
[1] Burnet Inst, Dis Eliminat Program, Melbourne, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia
[3] La Trobe Univ, Sch Publ Hlth, Melbourne, Australia
[4] Alfred Hlth, Dept Infect Dis, Melbourne, Australia
[5] Monash Univ, Melbourne, Australia
来源
DRUGS HABITS AND SOCIAL POLICY | 2024年 / 25卷 / 01期
关键词
Homelessness; Hepatitis C; Public health; Social research; Injecting drug use; Unstable housing; VIRUS-INFECTION; HIV; HOMELESSNESS; HCV;
D O I
10.1108/DHS-08-2023-0034
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
PurposeGlobally, hepatitis C treatment uptake is lower among people who are homeless or unstably housed compared to those who are housed. Understanding and addressing this is essential to ensure no one is left behind in hepatitis C elimination efforts. This study aims to explore peoples' experiences of unstable housing and health care, and how these experiences influenced engagement in hepatitis C treatment.Design/methodology/approachPurposive sampling was used to recruit people with lived experience of injection drug use, hepatitis C and unstable housing in Melbourne, Australia. In-depth semistructured interviews were conducted and a case study approach with interpretative phenomenological analysis was used to identify personal experiential themes and group experiential themes.FindingsFour people were interviewed. The precarious nature of housing for women who inject drugs was a group experiential theme, however, this did not appear to be a direct barrier to hepatitis C treatment. Rather, competing priorities, including caregiving, were personal experiential themes and these created barriers to treatment. Another group experiential theme was "right place, right time, right people" with these three elements required to facilitate hepatitis C treatment.Originality/valueThere is limited research providing in-depth insight into how personal experiences with unstable housing and health care shape engagement with hepatitis C treatment. The analyses indicate there is a need to move beyond a "one size fits-all" approach to hepatitis C care. Instead, care should be tailored to the needs of individuals and their personal circumstances and regularly facilitated. This includes giving greater attention to gender in intervention design and evaluation, and research more broadly.
引用
收藏
页码:37 / 50
页数:14
相关论文
共 50 条
  • [21] WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs Comment
    Walsh, Nick
    Verster, Annette
    Rodolph, Michelle
    Akl, Elie A.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (03) : 363 - 371
  • [22] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30
  • [23] Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
    Clipman, Steven J.
    Mehta, Shruti H.
    Rodgers, Mary A.
    Duggal, Priya
    Srikrishnan, Aylur K.
    Saravanan, Shanmugam
    Balakrishnan, Pachamuthu
    Vasudevan, Canjeevaran K.
    Ray, Stuart C.
    Kumar, Muniratnam S.
    Quinn, Thomas C.
    Cloherty, Gavin A.
    Lucas, Gregory M.
    Solomon, Sunil S.
    HEPATOLOGY, 2021, 74 (04) : 1782 - 1794
  • [24] Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis
    Grantz, Kyra H.
    Cepeda, Javier
    Astemborski, Jacqueline
    Kirk, Gregory D.
    Thomas, David L.
    Mehta, Shruti H.
    Wesolowski, Amy
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)
  • [25] Enhancing engagement in hepatitis C care among people who inject drugs
    Marshall, Alison D.
    Madden, Annie
    Treloar, Carla
    ADDICTION, 2019, 114 (12) : 2104 - 2106
  • [26] Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
    Oluwaseun Falade-Nwulia
    Jada Hackman
    Shruti H. Mehta
    Sean D. McCormick
    Gregory D. Kirk
    Mark Sulkowski
    David Thomas
    Carl Latkin
    Oliver Laeyendecker
    Stuart C. Ray
    BMC Infectious Diseases, 20
  • [27] Global genotype distribution of hepatitis C viral infection among people who inject drugs
    Robaeys, Geert
    Bielen, Rob
    Azar, Darush Ghezel
    Razavi, Homie
    Nevens, Frederik
    JOURNAL OF HEPATOLOGY, 2016, 65 (06) : 1094 - 1103
  • [28] Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India
    Gupta, Debanjali
    Saha, Kallol
    Biswas, Aritra
    Firdaus, Rushna
    Ghosh, Monika
    Sadhukhan, Provash Chandra
    INFECTION GENETICS AND EVOLUTION, 2017, 48 : 156 - 163
  • [29] Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
    Delaunay, Charlotte Laniece
    Godin, Arnaud
    Kronfli, Nadine
    Panagiotoglou, Dimitra
    Cox, Joseph
    Alary, Michel
    Klein, Marina B.
    Maheu-Giroux, Mathieu
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
  • [30] Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California
    Ozga, Jenny E.
    Syvertsen, Jennifer L.
    Pollini, Robin A.
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (07) : 518 - 528